Who Supplies Vildagliptin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Vildagliptin exports, with 178+ registered manufacturers shipping to buyers across 87+ countries — yet a handful of companies dominate the shipments. AJANTA PHARMA LIMITED holds the largest share at 15.7% (export value: $1.6M). Close behind, EMCURE PHARMACEUTICALS LIMITED (9.4%, $952.7K). INTAS PHARMACEUTICALS LIMITED (7.7%, $779.5K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Vildagliptin? Top Manufacturers & Their Buyers
Flow of Vildagliptin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Vildagliptin Supplier Network — Key Market Intelligence
The Vildagliptin export market from India is led by AJANTA PHARMA LIMITED, which alone commands a 15.7% share, shipping $1.6M worth of product across 92 shipments. The second-largest exporter, EMCURE PHARMACEUTICALS LIMITED, contributes $952.7K (9.4%) to the overall market. Combined, the top two suppliers alone account for 25.1% of all Vildagliptin exports, indicating a relatively concentrated supply base.
Across all 178 tracked manufacturers, the total Vildagliptin export value stands at $10.2M from 1.1K shipments. The market average shipment value is $8.8K. The single largest buyer relationship in terms of trade value is PLANET PHARMA SA, receiving $1.3M worth of product.
The combined buyer network spans 19 named purchasing companies, including PLANET PHARMA SA, KAWKAB SCIENTIFIC BUREAU*, BRANCH OFFICE AJANTA, ASTRA PHARMA (T) LTD, EMCURE PHARMA CHILE S P A and 14 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1AJANTA PHARMA LIMITED
AJANTA PHARMA LIMITED is the first-largest Vildagliptin exporter from India, with a market share of 15.7% and a total export value of $1.6M across 92 shipments. Their average shipment value of $17.4K is above the market average of $8.8K, suggesting premium or bulk contract pricing.
AJANTA PHARMA LIMITED serves 5 named buyers in our database. PLANET PHARMA SA is the dominant customer, accounting for 81.3% of this supplier's tracked business. Top customers include:
• PLANET PHARMA SA — $1.3M across 75 shipments (81.3% of this supplier's total exports)
• KAWKAB SCIENTIFIC BUREAU* — $147.4K across 8 shipments (9.2% of this supplier's total exports)
• KAWKAB SCIENTIFIC BUREAU* — $121.6K across 7 shipments (7.6% of this supplier's total exports)
• BRANCH OFFICE AJANTA — $15.1K across 1 shipments (0.9% of this supplier's total exports)
• ASTRA PHARMA (T) LTD — $14.7K across 1 shipments (0.9% of this supplier's total exports)
Key Insight: AJANTA PHARMA LIMITED's per-shipment value of $17.4K is 97% above the market average of $8.8K, consistent with large-order contracts or value-added formulations.
2EMCURE PHARMACEUTICALS LIMITED
EMCURE PHARMACEUTICALS LIMITED is the second-largest Vildagliptin exporter from India, with a market share of 9.4% and a total export value of $952.7K across 64 shipments. Their average shipment value of $14.9K is above the market average of $8.8K, suggesting premium or bulk contract pricing.
EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. EMCURE PHARMA CHILE S P A is the dominant customer, accounting for 70.3% of this supplier's tracked business. Top customers include:
• EMCURE PHARMA CHILE S P A — $669.4K across 45 shipments (70.3% of this supplier's total exports)
• EMCURE PHARMA CHILE S P A — $219.5K across 15 shipments (23.0% of this supplier's total exports)
• THE MAURITIUS PHARMA — $31.4K across 2 shipments (3.3% of this supplier's total exports)
• EMCURE CHILE SPA — $18.4K across 1 shipments (1.9% of this supplier's total exports)
• EMCURE PHARMA PERU S — $14.0K across 1 shipments (1.5% of this supplier's total exports)
Key Insight: EMCURE PHARMACEUTICALS LIMITED's per-shipment value of $14.9K is 68% above the market average of $8.8K, consistent with large-order contracts or value-added formulations.
3INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the third-largest Vildagliptin exporter from India, with a market share of 7.7% and a total export value of $779.5K across 53 shipments. Their average shipment value of $14.7K is above the market average of $8.8K, suggesting premium or bulk contract pricing.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. BROCACEF NL DUTCH is the dominant customer, accounting for 79.6% of this supplier's tracked business. Top customers include:
• BROCACEF NL DUTCH — $620.6K across 42 shipments (79.6% of this supplier's total exports)
• BROCACEF NL DUTCH — $64.5K across 4 shipments (8.3% of this supplier's total exports)
• Brocacef NL HUB — $39.4K across 3 shipments (5.1% of this supplier's total exports)
• BROCACEF NL:EU HUB — $27.6K across 2 shipments (3.5% of this supplier's total exports)
• BROCACEF NL : LOCAL — $27.4K across 2 shipments (3.5% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $14.7K is 66% above the market average of $8.8K, consistent with large-order contracts or value-added formulations.
4INNOVA CAPTAB LIMITED
INNOVA CAPTAB LIMITED is the fourth-largest Vildagliptin exporter from India, with a market share of 7.0% and a total export value of $712.8K across 4 shipments. Their average shipment value of $178.2K is above the market average of $8.8K, suggesting premium or bulk contract pricing.
INNOVA CAPTAB LIMITED serves 1 named buyer in our database. AL HILAL PHARMACY is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• AL HILAL PHARMACY — $712.8K across 4 shipments (100.0% of this supplier's total exports)
Key Insight: INNOVA CAPTAB LIMITED's per-shipment value of $178.2K is 1916% above the market average of $8.8K, consistent with large-order contracts or value-added formulations.
5MICRO LABS LIMITED
MICRO LABS LIMITED is the fifth-largest Vildagliptin exporter from India, with a market share of 4.5% and a total export value of $452.7K across 15 shipments. Their average shipment value of $30.2K is above the market average of $8.8K, suggesting premium or bulk contract pricing.
MICRO LABS LIMITED serves 5 named buyers in our database. AL-KAWKAB SCIENTIFIC BUREAU is the dominant customer, accounting for 88.1% of this supplier's tracked business. Top customers include:
• AL-KAWKAB SCIENTIFIC BUREAU — $398.9K across 13 shipments (88.1% of this supplier's total exports)
• LABOREX TANZANIA LIM — $25.4K across 1 shipments (5.6% of this supplier's total exports)
• PHARMA VISION (PTY) — $23.1K across 1 shipments (5.1% of this supplier's total exports)
• ALCHEM INDUSTRIES SU — $3.4K across 0 shipments (0.8% of this supplier's total exports)
• WESSEX PHARMACEUTICA — $1.8K across 0 shipments (0.4% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED's per-shipment value of $30.2K is 241% above the market average of $8.8K, consistent with large-order contracts or value-added formulations.
6CADILA PHARMACEUTICALS LIMITED
CADILA PHARMACEUTICALS LIMITED is the fifth-largest Vildagliptin exporter from India, with a market share of 1.7% and a total export value of $168.2K across 22 shipments. Their average shipment value of $7.6K is below the market average of $8.8K, reflecting a high-volume, competitive pricing strategy.
CADILA PHARMACEUTICALS LIMITED serves 1 named buyer in our database. TECNIMEDE SOCIEDADE TECNICO MEDICIN is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• TECNIMEDE SOCIEDADE TECNICO MEDICIN — $168.2K across 22 shipments (100.0% of this supplier's total exports)
Key Insight: CADILA PHARMACEUTICALS LIMITED operates with high shipment frequency (22 shipments) at a per-shipment value of $7.6K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Vildagliptin Flows
Once Vildagliptin leaves the manufacturing plants of companies like AJANTA PHARMA LIMITED and EMCURE PHARMACEUTICALS LIMITED, it travels to 5 destination markets with a combined import value of $10.2M. France absorbs the largest share at 14.4% ($1.5M), followed by Portugal (10.1%) and Chile (9.1%).
In France — the top destination — named importers include PLANET PHARMA SA. In Portugal, key buyers are TECNIMEDE SOCIEDADE TECNICO MEDICIN.
This geographic spread reflects Vildagliptin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Vildagliptin Go? Top Importing Countries & Their Buyers
Trade flow of Vildagliptin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1France
France ranks as the first-largest destination for Vildagliptin imports from India, with a total trade value of $1.5M across 48 shipments — representing a 14.4% share of all Vildagliptin exports. The average shipment value of $30.6K is above the global average of $8.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Vildagliptin importers in France: PLANET PHARMA SA is the largest buyer, accounting for 97.7% ($1.4M) of this market's total imports.
• PLANET PHARMA SA — $1.4M (97.7% of France's total)
Key Insight: France's per-shipment average of $30.6K (246% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Vildagliptin imports from India.
2Portugal
Portugal ranks as the second-largest destination for Vildagliptin imports from India, with a total trade value of $1.0M across 22 shipments — representing a 10.1% share of all Vildagliptin exports. The average shipment value of $46.6K is above the global average of $8.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Vildagliptin importers in Portugal: TECNIMEDE SOCIEDADE TECNICO MEDICIN is the largest buyer, accounting for 100.0% ($1.0M) of this market's total imports.
• TECNIMEDE SOCIEDADE TECNICO MEDICIN — $1.0M (100.0% of Portugal's total)
Key Insight: Portugal's per-shipment average of $46.6K (427% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Portugal is a key market for Vildagliptin imports from India.
3Chile
Chile ranks as the third-largest destination for Vildagliptin imports from India, with a total trade value of $923.6K across 31 shipments — representing a 9.1% share of all Vildagliptin exports. The average shipment value of $29.8K is above the global average of $8.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Vildagliptin importers in Chile: EMCURE PHARMA CHILE S.P.A. is the largest buyer, accounting for 72.5% ($669.4K) of this market's total imports.
• EMCURE PHARMA CHILE S.P.A. — $669.4K (72.5% of Chile's total)
• EMCURE PHARMA CHILE S P A — $219.5K (23.8% of Chile's total)
Key Insight: Chile's per-shipment average of $29.8K (237% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Chile is a key market for Vildagliptin imports from India.
4Netherlands
Netherlands ranks as the fourth-largest destination for Vildagliptin imports from India, with a total trade value of $850.5K across 7 shipments — representing a 8.4% share of all Vildagliptin exports. The average shipment value of $121.5K is above the global average of $8.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Vildagliptin importers in Netherlands: BROCACEF NL DUTCH is the largest buyer, accounting for 76.1% ($647.1K) of this market's total imports.
• BROCACEF NL DUTCH — $647.1K (76.1% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $121.5K (1274% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Vildagliptin imports from India.
5Yemen
Yemen ranks as the fifth-largest destination for Vildagliptin imports from India, with a total trade value of $807.5K across 4 shipments — representing a 7.9% share of all Vildagliptin exports. The average shipment value of $201.9K is above the global average of $8.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Vildagliptin importers in Yemen: AL HILAL PHARMACY is the largest buyer, accounting for 89.3% ($720.7K) of this market's total imports.
• AL HILAL PHARMACY — $720.7K (89.3% of Yemen's total)
Key Insight: Yemen's per-shipment average of $201.9K (2183% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Yemen is a key market for Vildagliptin imports from India.
People Also Ask — Vildagliptin Supplier & Trade Network
Who are the top suppliers of Vildagliptin from India?+
Which companies buy Vildagliptin from Indian manufacturers?+
Where does Vildagliptin exported from India go?+
What is the market share of the top Vildagliptin supplier from India?+
What is the average shipment value for Vildagliptin exports from India?+
Is Vildagliptin manufactured in India and exported globally?+
Which country imports the most Vildagliptin from India?+
Who are the buyers of Vildagliptin in Portugal?+
How concentrated is the Vildagliptin supplier market in India?+
How do I find verified buyers for Vildagliptin in specific countries?+
Vildagliptin Trade Network — Key Takeaways
- 1AJANTA PHARMA LIMITED is India's dominant Vildagliptin exporter with a 15.7% market share and $1.6M in total exports — making it the single most important sourcing entity in this market.
- 2The top 178 suppliers collectively account for 45.9% of all tracked Vildagliptin exports, with a combined trade value of $10.2M.
- 3France is the largest destination market, absorbing 14.4% of India's Vildagliptin exports ($1.5M). Portugal (10.1%) and Chile (9.1%) follow.
- 4With 1.1K total shipments averaging $8.8K each, the Vildagliptin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include PLANET PHARMA SA, KAWKAB SCIENTIFIC BUREAU*, EMCURE PHARMA CHILE S P A, EMCURE PHARMA CHILE S P A — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 87 countries
Network value: $10.2M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vildagliptin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Vildagliptin.
- 2.Flow Mapping: 178 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,149 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 87 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,149 Verified Shipments
178 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists